Data / Drug companies / Vitamin D Analog
Vitamin D Analog drugs: 4 drugs from 19 companies in the FDA NDC directory
Vitamin D Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 49 products in this class from 19 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 19Companies
- 49Products
- 4Drugs by generic name
Drugs in the Vitamin D Analog class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Paricalcitol | 27 | 13 |
| Calcipotriene | 11 | 7 |
| Calcipotriene and betamethasone dipropionate | 7 | 6 |
| Calcipotriene, betamethasone dipropionate | 4 | 3 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| AbbVie Inc. | 4 | injection, solution; capsule, liquid filled | New drug applications (NDA) | April 20, 2018 |
| Amneal Pharmaceuticals LLC | 4 | injection | Generic drugs (ANDA) | March 9, 2017 |
| Bryant Ranch Prepack | 4 | capsule; ointment | Generic drugs (ANDA) | January 30, 2020 |
| Eugia US LLC | 4 | injection | Generic drugs (ANDA) | October 9, 2018 |
| Amneal Pharmaceuticals LLC | 3 | capsule | Generic drugs (ANDA) | January 15, 2016 |
| Aurobindo Pharma Limited | 3 | capsule, liquid filled | Generic drugs (ANDA) | January 14, 2016 |
| Bionpharma Inc. | 3 | capsule | Generic drugs (ANDA) | August 16, 2016 |
| Bryant Ranch Prepack | 3 | capsule; ointment | Generic drugs (ANDA) | January 30, 2020 |
| Prasco Laboratories | 3 | ointment; cream | Authorized generics (NDA) | January 28, 2020 |
| Sun Pharmaceutical Industries, Inc. | 3 | ointment; suspension | Generic drugs (ANDA) | September 2, 2020 |
| Accord Healthcare Inc. | 2 | injection, solution | New drug applications (NDA) | March 24, 2016 |
| Cosette Pharmaceuticals, Inc. | 2 | solution; suspension | Generic drugs (ANDA) | August 2, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 2 | cream; ointment | Generic drugs (ANDA) | June 10, 2015 |
| Leo Pharma Inc. | 2 | suspension; aerosol, foam | New drug applications (NDA) | October 16, 2015 |
| Mayne Pharma Inc. | 2 | aerosol, foam | New drug applications (NDA) | February 15, 2021 |
| Perfero Pharma, Inc. | 2 | solution | Generic drugs (ANDA) | June 1, 2026 |
| MC2 Therapeutics Ltd | 1 | cream | New drug applications (NDA) | June 30, 2021 |
| NorthStar Rx LLC | 1 | cream | Generic drugs (ANDA) | June 1, 2015 |
| Padagis Israel Pharmaceuticals Ltd | 1 | ointment | Generic drugs (ANDA) | January 30, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 10 | 20.4% |
| Ointment | 9 | 18.4% |
| Injection | 8 | 16.3% |
| Capsule, liquid filled | 5 | 10.2% |
| Injection, solution | 4 | 8.2% |
| Cream | 4 | 8.2% |
| Solution | 3 | 6.1% |
| Suspension | 3 | 6.1% |
| Aerosol, foam | 3 | 6.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.